Assessing the Demand for & Strategy to Identify & Optimize Dual Payload ADC Combinations to Combat Classical Cytotoxic Resistance Mechanisms

  • Contextualizing the need for novel payloads and payload combinations to circumvent resistance mechanisms to Topo1 and other classical payloads
  • Breaking down a rationale-driven approach for novel payload combinations beyond dual cytotoxics
  • Laying out preclinical approaches to identify and optimize dual payload combinations to set up translation for success